复宏汉霖再涨超8% 公司在ASCO年会发布H药汉斯状 及HLX43多项研究成果

智通财经
04 Jun

复宏汉霖(02696)再涨超8%,截至发稿,涨7.17%,报49.35港元,成交额5916.87万港元。消息面上,6月1日,复宏汉霖宣布,公司自主研发的创新型抗PD-1单抗H药汉斯状(斯鲁利单抗,欧洲商品名:Hetronifly)肺癌和消化道肿瘤领域十余项研究最新结果在2025年美国临床肿瘤学会(ASCO)年会上发布。H药汉斯状是全球首个获批一线治疗小细胞肺癌的抗PD-1单抗,已在中国、欧洲和...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10